(ADUS) Addus HomeCare - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0067391062

ADUS: Personal Care, Hospice, Home Health

Addus HomeCare Corporation (NASDAQ:ADUS) operates in the critical segment of home healthcare, providing essential services to the elderly, chronically ill, and disabled. Their services span three key areas: Personal Care, Hospice, and Home Health, each addressing distinct patient needs. The Personal Care segment focuses on non-medical assistance, including daily living activities, while Hospice offers palliative care for terminally ill patients. The Home Health segment provides skilled medical care, crucial for recovery post-hospitalization.

As a player in the healthcare services industry, Addus is strategically positioned to benefit from the growing demand for cost-effective, home-based care. Their services are reimbursed by government agencies, managed care organizations, and private payors, highlighting their integral role in the healthcare system. Founded in 1979 and headquartered in Frisco, Texas, Addus has established a strong presence with a market cap of approximately $2.05 billion.

Financially, Addus presents an interesting profile with a trailing P/E of 25.91 and a forward P/E of 19.01, indicating expectations of future growth. The price-to-book ratio of 2.21 suggests the market values their assets and potential. With a price-to-sales ratio of 1.81, investors may consider the companys revenue generation efficiency.

For investors, Addus represents a strategic investment in a sector poised for growth due to aging demographics and the shift towards home healthcare. Their diversified service offerings and cost-effective care model position them well to capitalize on these trends, making them a compelling consideration for those looking to invest in healthcare services.

Additional Sources for ADUS Stock

ADUS Stock Overview

Market Cap in USD 1,763m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 2009-10-28

ADUS Stock Ratings

Growth 5y 39.3%
Fundamental 40.3%
Dividend 0.0%
Rel. Strength Industry -8.73
Analysts 4.5/5
Fair Price Momentum 76.23 USD
Fair Price DCF 105.70 USD

ADUS Dividends

No Dividends Paid

ADUS Growth Ratios

Growth Correlation 3m -78.4%
Growth Correlation 12m 37.6%
Growth Correlation 5y 36.6%
CAGR 5y 11.22%
CAGR/Max DD 5y 0.25
Sharpe Ratio 12m -0.22
Alpha -18.60
Beta 1.00
Volatility 32.39%
Current Volume 207.7k
Average Volume 20d 240.1k
What is the price of ADUS stocks?
As of March 15, 2025, the stock is trading at USD 90.28 with a total of 207,734 shares traded.
Over the past week, the price has changed by -6.96%, over one month by -20.26%, over three months by -30.77% and over the past year by -7.92%.
Is Addus HomeCare a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Addus HomeCare (NASDAQ:ADUS) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.33 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ADUS as of March 2025 is 76.23. This means that ADUS is currently overvalued and has a potential downside of -15.56%.
Is ADUS a buy, sell or hold?
Addus HomeCare has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy ADUS.
  • Strong Buy: 8
  • Buy: 3
  • Hold: 0
  • Sell: 1
  • Strong Sell: 0
What are the forecast for ADUS stock price target?
According to ValueRays Forecast Model, ADUS Addus HomeCare will be worth about 84.1 in March 2026. The stock is currently trading at 90.28. This means that the stock has a potential downside of -6.9%.
Issuer Forecast Upside
Wallstreet Target Price 136.3 50.9%
Analysts Target Price 137.8 52.7%
ValueRay Target Price 84.1 -6.9%